ASSESSING THE COST-UTILITY OF ETELCALCETIDE: A MARKOV MODEL

被引：0
|
作者：
Stollenwerk, B. [1 ]
Iannazzo, S. [2 ]
Akehurst, R. [3 ]
Adena, M. [4 ]
Briggs, A. [5 ]
Dehmel, B. [6 ]
Parfrey, P. [7 ]
Belozeroff, V [6 ]
机构：
[1] Amgen Europe GmbH, Zug, Switzerland
[2] SIHS SRL, Turin, Italy
[3] BresMed Hlth Solut, Sheffield, S Yorkshire, England
[4] Datalyt Pty Ltd, Bruce, ACT, Australia
[5] Univ Glasgow, Glasgow, Lanark, Scotland
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
[7] Mem Univ, St John, NF, Canada
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK18
引用
收藏
页码：A519 / A519
页数：1
相关论文
共 50 条
  • [21] Communication channels and risk information - A cost-utility model
    Trumbo, C
    SCIENCE COMMUNICATION, 1998, 20 (02) : 190 - 203
  • [22] Cost-utility analysis of cataract surgery in Japan: a probabilistic Markov modeling study
    Hiratsuka, Yoshimune
    Yamada, Masakazu
    Akune, Yoko
    Murakami, Akira
    Okada, Annabelle A.
    Yamashita, Hidetoshi
    Ohashi, Yuichi
    Yamagishi, Naoya
    Tamura, Hiroshi
    Fukuhara, Shunichi
    Takura, Tomoyuki
    Eguchi, Shuichiro
    Akune, Yoko
    Yamada, Masakazu
    Kurosaka, Daijiro
    Takahashi, Kenichi
    Miyake, Sampei
    Hirose, Hiroshi
    Otori, Yasumasa
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2013, 57 (04) : 391 - 401
  • [23] Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
    Tang, Jianjun
    Liang, Yuanbo
    O'Neill, Ciaran
    Kee, Frank
    Jiang, Junhong
    Congdon, Nathan
    LANCET GLOBAL HEALTH, 2019, 7 (07): : E968 - E978
  • [24] Cost-effectiveness and cost-utility of population-based glaucoma screening in China: A decision-analytic Markov model
    Congdon, Nathan G.
    Tang, Jianjun
    Liang, Yuanbo
    O'Neill, Ciaran
    Kee, Frank
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [25] A Cost-Utility Model of Care for Peristomal Skin Complications
    Neil, Nancy
    Inglese, Gary
    Manson, Andrea
    Townshend, Arden
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2016, 43 (01) : 62 - 68
  • [26] A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder
    Armstrong, Edward P.
    Malone, Daniel C.
    Erder, M. Haim
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (04) : 1115 - 1121
  • [27] Cost-utility analysis of cataract surgery in Japan: a probabilistic Markov modeling study
    Japanese Journal of Ophthalmology, 2013, 57 : 391 - 401
  • [28] Assessing adolescent immunization options for pertussis in Canada: A cost-utility analysis
    Anyiwe, Kika
    Richardson, Marina
    Brophy, Jason
    Sander, Beate
    VACCINE, 2020, 38 (07) : 1825 - 1833
  • [29] Assessing the Cost-Utility of Universal Hepatitis B Vaccination Among Adults
    Hall, Eric W.
    Weng, Mark K.
    Harris, Aaron M.
    Schillie, Sarah
    Nelson, Noele P.
    Ortega-Sanchez, Ismael R.
    Rosenthal, Elizabeth
    Sullivan, Patrick S.
    Lopman, Ben
    Jones, Jeb
    Bradley, Heather
    Rosenberg, Eli S.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (06): : 1041 - 1051
  • [30] Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations
    Tennvall, GR
    Apelqvist, J
    DIABETOLOGIA, 2001, 44 (11) : 2077 - 2087
12345